TRANSCAT INC
TRNSNASDAQTrading Snapshot
- Day Range
- $288.05 β $295.77
- 52-Week Range
- $50.23 β $100.00
- Volume
- $1.92B
- Avg Volume
- $1.84B
- Shares Outstanding
- 9.4M
- Next Earnings
- Nov 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $332M
- Last Q Revenue
- $93M
- P/E Ratio
- 238.3
- P/S Ratio
- 2.4x
- EPS (TTM)
- $0.36
- Dividend Yield
- β
- Dilution (1yr)
- +1.5%
Why Investors Own TRNS
- βHigh-growth profile β revenue up +50.4% YoY with expanding US Equity exposure.
- βHealthy economics β 75% gross margin and 21% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
TRANSCAT INC
TRNSAbout TRANSCAT INC
Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciencesβencompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
TRANSCAT INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift TRNS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
TRANSCAT INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.